Clinical trial

A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and…

NCT00188942 · University Health Network, Toronto, Other · Completed

Key facts

NCT number NCT00188942
Title A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
Official title Neural Correlates of Emotional Processing in Depressed and Remitted Bipolar and Unipolar Depressed Subjects: An fMRI Investigation
Lead sponsor University Health Network, Toronto, Other
Collaborators Eli Lilly and Company Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Major Depressive Disorder
Intervention type Drug, Procedure
Interventions Fluoxetine+Olanzapine, Olanzapine, Functional Magnetic Resonance Imaging
Enrollment 42
Start date Feb 1, 2005
Primary completion Jun 1, 2009
Completion Jun 1, 2009
First posted Sep 16, 2005
Last update posted Feb 8, 2013
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies